Peng Sun
About Peng Sun
Peng Sun is a Senior Study Physician at Bristol-Myers Squibb with 14 years of experience in clinical development and drug discovery, specializing in virology, oncology, and immunology.
Company
Peng Sun is currently employed at Bristol-Myers Squibb as a Senior Study Physician. His role involves serving as the clinical lead on immuno-oncology (IO-IO/IO-CRT) treatment for non-small cell lung cancer (NSCLC) and squamous cell carcinoma of the head and neck (SCCHN) clinical studies. Bristol-Myers Squibb is known for its robust focus on innovative therapies in oncology, immunology, and other critical disease areas.
Title
Peng Sun holds the position of Senior Study Physician. In this capacity, he plays a crucial role in overseeing clinical studies and protocols, primarily focusing on oncology treatments. His responsibilities include ensuring clinical trial protocol compliance, facilitating communication between investigatory sites and regulatory agencies, and contributing to the strategic direction of clinical trial developments.
Education and Expertise
Peng Sun earned his Doctor of Philosophy (PhD) in Cancer Biology and Immunology from the University of Glasgow, where he studied from 2001 to 2006. Prior to this, he achieved his Doctor of Medicine (MD) from Qingdao University Medical College, studying Medicine from 1992 to 1997. Peng has a broad knowledge base in small molecule and biologic therapeutics development, and extensive experience with clinical trial protocol assessments adhering to GCP and ICH guidelines.
Background
Peng Sun has accumulated extensive experience over 14 years in clinical development and drug discovery, with a special focus on virology, oncology, and immunology. During his career, he has worked at various prestigious institutions, including TESARO, Inc., Baxalta, MD Anderson Cancer Center, Johns Hopkins School of Medicine, and Qingdao Shili Hospital. His global experience spans roles in the United States and China, enhancing his diverse skill set and extensive knowledge in the medical field.
Achievements
Peng Sun has a well-established record in medical and scientific editing, reviews, publications, and grant applications. During his tenure, he has led various critical studies and has been instrumental in clinical lead roles in oncology trials at Bristol-Myers Squibb. With substantial experience working with the FDA and adhering to international guidelines, Peng has proved his competency in ensuring the highest standards in clinical research and drug development.